je.st
news
Tag: analysis
ANALYSIS: Asos a structural winner in apparel retail
2014-06-16 16:22:00| Daily apparel & textile news and comment - from just-style.com
Online fashion retailer Asos is a structural winner in apparel retail, analysts believe, despite the group issuing a profit warning earlier this month on the back of slowing international sales.
Tags: analysis
retail
apparel
winner
Analysis - Brown-Forman evolution adds edge to Europe drive
2014-06-16 16:07:00| Daily beverage news and comment - from just-drinks.com
With all-American brands such as Jack Daniel's and Woodford Reserve, Brown-Forman is very much at home in its domestic US market.
Tags: analysis
drive
europe
edge
Data Analysis Software tests and maintains CAN networks.
2014-06-16 14:31:15| Industrial Newsroom - All News for Today
Suited for industrial and automotive systems, IXXAT canAnalyser v3 supports up to 64 CAN channels simultaneously with Multi-Board Support, and displays information by means of uniform time base. Signal transmit module enables network devices to be simulated on process level without underlying CAN communication having to be known in detail. Statistics scripts, for analysis of frequency distributions, repeat times, and response/run-times, are in source code and can be adapted to user requirements. This story is related to the following:Testing Software | Data Analysis Software |
Tags: data
software
analysis
networks
ANALYSIS: China law changes tighten up on textile pollution
2014-06-16 14:14:00| Daily apparel & textile news and comment - from just-style.com
Sweeping changes approved this year to China's national Environmental Protection Law could push consolidation in the textile and clothing industry as compliance costs rise.
Tags: china
law
analysis
pollution
New Post-Hoc Analysis Shows Patients with Type 2 Diabetes Undergoing Intensification of Insulin Therapy Experienced Less Nighttime Hypoglycemia While Being Treated with JANUVIA (sitagliptin) Compared to Placebo
2014-06-14 19:01:06| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced results from a post-hoc analysis showing that patients with type 2 diabetes having treatment intensified with insulin glargine therapy while also being treated with JANUVIA (sitagliptin) 100 mg once-daily had a lower incidence of nighttime (nocturnal) hypoglycemia compared to patients also receiving placebo. Results were presented at the American Diabetes Association 74th Scientific Sessions. Language: English read more
Sites : [471] [472] [473] [474] [475] [476] [477] [478] [479] [480] [481] [482] [483] [484] [485] [486] [487] [488] [489] [490] next »